Venetian-1 Acquisition Corp. |
President and COO, Director |
Common Stock |
2.68M |
$10.7M |
$4.00 |
Nov 1, 2024 |
By TPAV, LLC |
Traws Pharma, Inc. |
Chief Operating Officer, Director |
Common Stock |
134K |
$63.1K |
$0.47 |
Apr 1, 2024 |
Direct |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Stock Option (right to purchase) |
3.8M |
|
|
Apr 1, 2024 |
Direct |
Venetian-1 Acquisition Corp. |
President and COO, Director |
Stock Option (Right to Buy) |
1.26M |
|
|
Nov 1, 2024 |
Direct |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Series C Preferred Stock |
4.8K |
|
|
Apr 1, 2024 |
By Viriom, Inc. |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Series C Preferred Stock |
2.58K |
|
|
Apr 1, 2024 |
By TPAV, LLC |
Onconova Therapeutics, Inc. |
Chief Operating Officer, Director |
Series C Preferred Stock |
195 |
|
|
Apr 1, 2024 |
Direct |
Venetian-1 Acquisition Corp. |
President and COO, Director |
Simple Agreement for Future Equity |
0 |
|
|
Nov 1, 2024 |
By TPAV, LLC |